EPO Patents = 1

Forward Citations = 10

Loading Chart...

2 inventors (with patents filed for the assignee):

Xiaofang Wang (5 out of 7 patents)

Ren-He Xu (5 out of 5 patents)

Ren-He Xu (0 patent)

5 patents: Sort by Forward Citations

1. 10842826 - Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof (2020-11-24),

2. 10557122 - Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof (2020-02-11),

3. 10226488 - Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof (2019-03-12),

4. 9745551 - Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof (2017-08-29),

5. 9725698 - Trophoblast-derived mesenchymal stem cells (T-MSCs) produced from human embryonic stem cells, methods and uses thereof (2017-08-08),

Company Overview

Imstem Biotechnology, Inc. is a leading biotechnology company focused on developing innovative stem cell-based therapies for various medical conditions. With a team of experienced researchers and scientists, Imstem is dedicated to advancing the field of regenerative medicine and improving patient outcomes. Visit our website to learn more about our groundbreaking research and cutting-edge technologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#28 in Farmington, CT

#1,030 in Connecticut

#51,570 in US

Farmington, CT, United States of America

Imstem Biotechnology, Inc.

Forward Citations = 10

2 inventors:

Xiaofang Wang (5 out of 7 patents)

Ren-He Xu (5 out of 5 patents)

Ren-He Xu (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Imstem Biotechnology, Inc.. Retrieved from https://idiyas.com/company/imstem-biotechnology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]